Daily Intravesical Instillation of 1 mg Nociceptin/Orphanin FQ for the Control of Neurogenic Detrusor Overactivity: A Multicenter, Placebo Controlled, Randomized Exploratory Study
Massimo Lazzeri(IRCCS Humanitas Research Hospital), Damiano Turini(University of Ferrara), Remo Guerrini(University of Ferrara), S. Malaguti(University of Ferrara), M. Spinelli, D. Regoli(University of Ferrara), Patrizia Beneforti(University of Ferrara), Severo Salvadori(University of Ferrara), Girolamo Calò(University of Padua)
Cited by 35
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Pharmacology of nociceptin and its receptor: a novel therapeutic target
|British Journal of Pharmacology|2000|432
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization
|Trends in Pharmacological Sciences|1988|358